van der Klaauw, Agatha A. http://orcid.org/0000-0001-6971-8828
Horner, Emily C. http://orcid.org/0000-0003-2226-1028
Pereyra-Gerber, Pehuén
Agrawal, Utkarsh http://orcid.org/0000-0001-5181-6120
Foster, William S. http://orcid.org/0000-0002-7103-3657
Spencer, Sarah
Vergese, Bensi
Smith, Miriam
Henning, Elana
Ramsay, Isobel D. http://orcid.org/0000-0002-9954-2023
Smith, Jack A. http://orcid.org/0000-0001-6654-5706
Guillaume, Stephane M. http://orcid.org/0000-0003-2007-4608
Sharpe, Hayley J. http://orcid.org/0000-0002-4723-298X
Hay, Iain M. http://orcid.org/0000-0002-5451-1768
Thompson, Sam
Innocentin, Silvia
Booth, Lucy H.
Robertson, Chris
McCowan, Colin http://orcid.org/0000-0002-9466-833X
Kerr, Steven
Mulroney, Thomas E.
O’Reilly, Martin J. http://orcid.org/0000-0003-1095-0328
Gurugama, Thevinya P.
Gurugama, Lihinya P.
Rust, Maria A.
Ferreira, Alex http://orcid.org/0000-0002-1964-1049
Ebrahimi, Soraya
Ceron-Gutierrez, Lourdes
Scotucci, Jacopo
Kronsteiner, Barbara http://orcid.org/0000-0003-0867-2867
Dunachie, Susanna J. http://orcid.org/0000-0001-5665-6293
Klenerman, Paul http://orcid.org/0000-0003-4307-9161
Park, Adrian J. http://orcid.org/0000-0003-2713-7595
Rubino, Francesco
Lamikanra, Abigail A.
Stark, Hannah
Kingston, Nathalie
Estcourt, Lise
Harvala, Heli
Roberts, David J.
Doffinger, Rainer
Linterman, Michelle A. http://orcid.org/0000-0001-6047-1996
Matheson, Nicholas J. http://orcid.org/0000-0002-3318-1851
Sheikh, Aziz http://orcid.org/0000-0001-7022-3056
Farooqi, I. Sadaf http://orcid.org/0000-0001-7609-3504
Thaventhiran, James E. D. http://orcid.org/0000-0001-8616-074X
,
Funding for this research was provided by:
Wellcome Trust (207462/Z/17/Z)
Article History
Received: 9 August 2022
Accepted: 7 April 2023
First Online: 11 May 2023
Competing interests
: A.S. is a member of the Scottish Government’s Standing Committee on Pandemic Preparedness and the Risk Stratification Subgroup of the UK Government’s New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). He was a member of AstraZeneca’s Thrombotic Thrombocytopenic Task Force. All roles are unremunerated. S.J.D. is a Scientific Advisor to the Scottish Parliament on COVID-19, for which she receives a fee. I.S.F. has consulted for Eli Lilly, Novo Nordisk and Rhythm Pharmaceuticals on weight loss drugs. All other authors have no conflicts of interest to declare.